Skip to content

Advertisement

  • Research
  • Open Access

Factors influencing on health-related quality of life in South Korean with chronic liver disease

Health and Quality of Life Outcomes201816:142

https://doi.org/10.1186/s12955-018-0964-1

  • Received: 9 February 2018
  • Accepted: 2 July 2018
  • Published:

Abstract

Background

The objective of this study was to determine health-related quality of life (HRQoL) among chronic liver disease (CLD) subjects in South Korea using EuroQol five-dimension questionnaire (EQ-5D).

Method

The sample consisted of 139 subjects with CLD from the sixth Korean National Health and Nutrition Examination Survey (KNHNES VI). Data were analyzed using SPSS program for descriptive statistics, t-test, ANOVA, Scheffe’s test and hierarchical multiple regression.

Results

Results indicated that marital status (P < 0.01), occupation (P < 0.01), basic livelihood security recipient status (P < 0.05), hepatocellular carcinoma (P < 0.05), subjective health status (P < 0.01), and depression (P < 0.001) were significant predictors of HRQoL. Health behaviors (alcohol intake, sleep duration) variables were insignificant.

Conclusion

In conclusion, marital status, occupation, basic livelihood security recipient status (BLSRS), hepatocellular carcinoma (HCC), subjective health status (SHS), and depression were confirmed to be factors affecting the HRQoL. We should be provide to continuous monitoring and education of adequate alcohol intake for patients with CLD. Findings of this study might be used to develop community based health programs and policies for CLD.

Keywords

  • Chronic liver disease
  • Quality of life
  • EQ-5D

Background

CLD is one of the most prevalent diseases in the world. In Korea, CLD is a major disease with high prevalence along with hypertension and diabetes. According to Korea Statistics Office [1], CLD accounted for 13.3% of deaths in Korea, ranking the 8th in mortality rate in 2016. Most CLDs are caused by hepatitis B virus or hepatitis C virus, excessive alcohol consumption, fatty liver, and inflammatory reaction and healing process that are repeated for a long period of time, leading to progression to cirrhosis or liver cancer. Korea has the highest liver cancer mortality rate among OECD countries, with the highest prevalence of CLD among men in their 40s who are socially most productive. For this reason, CLD is becoming a social issue not only for the health of the individual, but also for the disease burden worldwide [2, 3].

People with CLD may suffer from specific complications of cirrhosis such as ascites, hepatic encephalopathy, and variceal bleeding. Moreover, fatigue, joint pain, skin itching, loss of appetite, depression, loss of libido, and problem of memory are associated CLD. Furthermore, CLD is linked to job loss, impaired functioning, anxiety, and low self-esteem that severely affect the quality of life [46]. In a previous study, it has been emphasized that a combination of psycho-social aspects and treatment is an important factor that determines the quality of life of CLD patients [4]. Therefore, the HRQoL of patients with CLD is an important outcome that should be considered for the treatment and prognosis of such patients [7].

The HRQoL of patients with chronic illness is affected by SHS and disease progression. CLD is not only a physical problem. It also affects a comprehensive range of physical and psycho-social aspects such as self-care, daily life activities, anxiety, and depression of patients [8, 9]. Previous studies have reported that age, gender, economic status, depression, self-efficacy, types of CLD, stage of disease, family history of CLD, and comorbidities are influencing factors of HRQoL [2, 4, 8, 10, 11]. However, the HRQoL of patients with CLD is not as well studied as other chronic diseases. In particular, nursing does not pay particular attention to factors that affect the quality of life of patients with CLD [12]. In South Korea, a few studies have compared HRQoL of CLD patients to that of patients with other chronic diseases [1315].

It is necessary to grasp the quality of life of CLD by using the Korea National Health and Nutrition Examination Survey (KNHANES) data for the management of appropriate chronic diseases. KNHANES is conducted every year to evaluate the current state of the public’s health and nutritional status, the health vulnerable group, the effectiveness of health policy and project, and the quality of life by disease [16]. Therefore, the aim of this study was to identify factors influencing the HRQoL of patients with CLD in Korea using data from the 6th KNHANES. Results of this study could be used as a basis to develop nursing interventions and policies that contribute to improved quality of life for CLD subjects.

Methods

Data and study design

We performed a cross-sectional study using data from the sixth KNHANES. To identify factors influencing the HRQoL of subjects with CLD, we obtained raw data of the sixth KNHANES which was conducted for household members older than 1 year. The KNHANES was composed of health, nutrition, and examination questionnaires. The Korea Centers for Disease Prevention and Control (KCDC) conducts a KNHANES annually by sending trained surveyors to investigate a representative sample using a computer-assisted personal interviewing technique. We have obtained approval to use the raw data from the KCDC homepage.

There were 18,034 adults over 19 years old out of 22,948 people in the sixth KNHANES. For this study, 139 from 140 CLD subjects currently suffering from hepatitis B, hepatitis C, liver cirrhosis, and HCC were included after excluding one unfaithful respondent. In order to confirm the number of samples necessary for executing the regression analysis, we used G*power 3.1.5.program to calculate the size of subjects using intermediate effect size of .15, significance level of .05, power analysis of .80, and 10 predictive variables. A total of 118 subjects were judged as an appropriate number of samples.

Ethical considerations

KNHANES was an annual survey conducted by the Research Ethics Review Committee of the KCDC (No. 2013-07CON-03-4C, No. 2013-12EXP-03-5C, No. 2015–01-02-6C). All personal identification information was deleted from the data before analysis. Participants in this survey provided their informed consent.

Variable measurement

Health related quality of life (HRQoL)

HRQoL was measured using the EQ-5D (EuroQoL-5 dimension) developed by European EuroQoL Group [17] to measure overall health. EQ-5D consisted of mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Responses in each dimension were divided into three levels coded as ‘no problems-1,’ ‘moderate problem-2,’ and ‘severe problem-3’. In this study, we used the model developed by the KCDC [18] which applied weighted values for HRQoL in the Korean context to calculate the EQ-5D index score ranging from − 1 point (severe problem) to + 1 point (no problem).

Socio-demographic characteristics

For socio-demographic characteristics, age, gender, marital status, educational level, occupation, and BLSRS were surveyed.

Health status

Health status was measured by SHS, depression, perceived stress, degree of obesity, comorbidity, types of CLD, and current treatment for CLD. SHS was assessed using the question, ‘How do you think about your health status in usual?’. Participants were asked to choose one in a 5-points scale: very unhealthy (1 point), unhealthy (2 point), medium (3 point), healthy (4 point), and very healthy (5 point), with the higher score indicating the healthier. For data analysis of this study, answers of very healthy and healthy were categorized as ‘good health’ while all other answers were categorized as ‘poor health’. In practical terms, SHS is readily measured using a single- item question, and is often included in health surveys and as an outcome in many studies [19]. Depression was defined as having experienced depression in their daily life for more than 2 weeks in a year. It was measured as: ‘not depressed’ or ‘experienced of depression’. Perceived stress was classified as ‘yes’ if participant felt it in their everyday life ‘very much’ or ‘feel a lot’. All other responses were reclassified as ‘no.’ Degree of obesity was measured by body mass index (BMI) which was calculated by dividing body weight (kg) by the square of height (m2). BMI < 18.5 was classified as ‘underweight,’ ≤18.5  < 23.0 as ‘normal weight,’ ≤23.0  < 25.0 as ‘overweight,’ and ≥ 25.0 as ‘obese’ [20]. The metric was categorized as either ‘underweight/normal’ or ‘overweight/obese’. Comorbidity was operationalized as the number of chronic diseases diagnosed by a physician (i.e., hypertension, hyperlipidemia, diabetes, strokes, myocardial infarction, angina etc.). It was categorized as ‘without comorbidity’ or ‘with comorbidities’. The types of CLD were consisted of hepatitis B, hepatitis C, liver cirrhosis and HCC. Current treatment for CLD was categorized as either ‘yes’ or ‘no’.

Health behaviors

Health behaviors such as alcohol intake, smoking, regular health check-up, cancer screening, regular exercise, and sleep duration per day were measured. Those variables were categorized as either ‘yes’ or ‘no’. Alcohol intake was a single question about drinking in the past year. ‘How often do you alcohol intake in the past year?’ The answer is Likert 5 point scale, ‘no alcohol intake,’ ‘one time in a month,’ ‘about once in a month,’ ‘about 2-4 times a month,’ ‘around 2-3 times a week,’ and ‘more than 4 times a week.’ In this study, ‘No’ was used for ‘no alcohol intake’ and ‘Yes’ for ‘the others response.’ Smoking was a question ‘Do you smoke now?’ In the choices of responses were ‘daily smoking,’ ‘sometime smoking,’ ‘no smoking,’ and ‘smoked in the past but not currently smoking.’ In this study, ‘no smoking,’ and ‘smoked in the past but not currently smoking’ were reclassified as ‘non-smokers,’ and ‘the others’ were ‘smokers.’ The questions of regular health check-up and cancer screening were ‘Did you have regular health check-up during the recent two years?, and ‘Did you have cancer screening during the recent two years?’ Subjects answered the questions ‘Yes’ or ‘No.’ Regular exercise was criteria by Korea  Ministry of Health and Welfare [21] as a regular activity criterion for adults and elderly. The criteria was evaluated to ‘have regular exercise’ when ‘middle level activity’ for 2 h 30 min or more or ‘high level activity’ for 1 h 15 min or more, and the other exercise were reclassified to ‘no regular exercise.’ Sleep duration per day was categorized as ‘appropriate sleeping duration’ or ‘inappropriate sleeping duration.’ The criteria were developed by Hirshkowitz et al. [22]. Appropriate sleeping duration was changed by age. It was that young adults (18-25 years) were 6–11, adults (26–64) were 6–10, and older adults (≥ 65) were 5–9 h.

Data analysis

Data were analyzed using SPSS (Version 22, IBM, Armonk, NY, USA). Socio-demographic characteristics of subjects, health status, health behavior, and EQ-5D index were analyzed using frequency and percentage. Differences in EQ-5D index by socio-demographic characteristics, health status, and health behavior were identified using t-test, analysis of variance and posthoc-test was applied Scheffe’s test. Hierarchical multiple regression analyses were performed to predict the EQ-5D index. Dummy variables were marital status, occupation, BLSRS, SHS, depression, comorbidity, alcohol intake, and sleep duration per day. The Durbin-Watson statistic was 2.100, indicating no autocorrelation in residuals. Tolerance ranged from 0.413 to 0.916. Variance inflation factor ranged from 1.091  2.421, indicating an absence of multicollinearity, thus satisfying basic assumptions of regression. After eliminating cases where normalized residuals were larger than the absolute value (10 cases), we performed a rank regression analysis for 129 subjects. Hierarchical multiple regression analysis was performed using Model I (socio-demographic characteristics), Model II (health status), and Model III (health behaviors).

Results

HRQoL according to variables

Table 1 shows differences of mean in HRQoL according to socio-demographic characteristics, health status, and health behaviors of Korean CLD patients. The most frequent socio-demographic characteristics were ‘45  64 years’ (56.9%), ‘male’ (62.6%), ‘with partner’ (81.2%), ‘over college degree’ (28.8%), ‘with occupation’ (59.0%), and ‘basic livelihood security non-recipient’ (88.5%). The mean age of subjects was 55.3 ± 12.7 years. The HRQoL was found to differ significantly according to age (P < 0.05), marital status (P < 0 .01), education level (P < 0.01), occupation (P < 0.01), and BLSRS (P < 0.05). The most frequent characteristics of health status were ‘unhealthy’ (85.6%), ‘no depression’ (82.6%), ‘no perceived stress’ (75.4%), ‘normal/under-weight’ (64.0%), ‘no comorbidity’ (55.4%), and ‘current treatment for CLD’ (62.6%). The types of CLD were ‘hepatitis B’ (57.6%), ‘hepatitis C’ (5.8%), ‘liver cirrhosis’ (24.5%), and ‘HCC’ (12.2%). The HRQoL showed significant differences according to SHS (P < 0.001), depression (P < 0.05), type of CLD (P < 0.001), and comorbidity (P < 0.05). The most frequent health behaviors were ‘alcohol drinker’ (51.4%), ‘non-smoker’ (76.8%), ‘doing regular health check-up’ (76.8%), ‘doing cancer screening’ (70.5%), ‘regular exercise’ (54.0%), and ‘appropriate sleep duration’ (79.9%). The HRQoL also showed significant differences according to alcohol intake (P < 0.05) and sleeping duration (P < 0.01). The most frequent types of comorbidity were hypertension 31.7% and the mean BMI of subjects was 24.04 ± 3.05 (not in the table).
Table 1

HRQoL according to Characteristics of CLD subjects in South Korea (N = 139)

Characteristics

Categories

n(%)

EQ-5D Index

t-value (Scheffe’s test)

M ± SD

Socio-demographic

Age(years)

(M ± SD: 55.3 ± 12.7)

< 45a

27(19.4)

0.98 ± 0.04

3.414*

(a > c)

45  64b

79(56.9)

0.90 ± 0.19

≥ 65c

33(23.7)

0.89 ± 0.12

Gender

Male

87(62.6)

0.92 ± 0.17

0.780

Female

52(37.4)

0.90 ± 0.14

Marital statuse

Living with partner

108(81.2)

0.93 ± 0.16

2.860**

Living without partner

25(18.8)

0.83 ± 0.15

Education level

≤Elementary schoola

37(26.6)

0.83 ± 0.24

6.024**

(c,d>a)

Middle schoolb

24(17.3)

0.92 ± 0.11

High schoolc

38(27.3)

0.94 ± 0.11

≥Colleged

40(28.8)

0.96 ± 0.07

Occupation

Yes

82(59.0)

0.95 ± 0.11

3.307**

No

57(41.0)

0.86 ± 0.20

Basic livelihood security recipient

Yes

16(11.5)

0.80 ± 0.19

−2.621*

No

123(88.5)

0.93 ± 0.15

Health status

Subjective health status

Good

20(14.4)

0.99 ± 0.17

5.453***

Poor

119(85.6)

0.90 ± 0.17

Depressione

Yes

24(17.4)

0.82 ± 0.25

−2.083*

No

114(82.6)

0.93 ± 0.12

Perceived stresse

Yes

34(24.6)

0.86 ± 0.24

−1.739

No

104(75.4)

0.93 ± 0.12

Degree of obesity

Underweight/normal

89(64.0)

0.91 ± 0.18

−0.732

Overweight/obese

50(36.0)

0.93 ± 0.11

Comorbidity

Yes

62(44.6)

0.88 ± 0.19

−2.242*

No

77(55.4)

0.94 ± 0.12

Types of CLD

Hepatitis Ba

80(57.6)

0.94 ± 0.10

6.973***

( a,c,d>b)

Hepatitis Cb

8(5.8)

0.71 ± 0.44

Liver cirrhosisc

34(24.5)

0.87 ± 0.13

HCCd

17(12.2)

0.94 ± 0.13

Current treatment for CLD

Yes

87(62.6)

0.92 ± 0.15

0.444

No

52(37.4)

0.91 ± 0.17

Health behaviors

Alcohol intakee

Yes

71(51.4)

0.95 ± 0.11

2.555*

No

67(48.6)

0.88 ± 0.19

Smoking

Yes

32(23.2)

0.89 ± 0.23

−1.025

No

106(76.8)

0.92 ± 0.13

Regular medical check-upe

Yes

106(76.8)

0.92 ± 0.13

1.130

No

32(23.2)

0.88 ± 0.23

Cancer screening test

Yes

98(70.5)

0.92 ± 0.13

0.993

No

41(29.5)

0.89 ± 0.21

Regular exercise

Yes

64(46.0)

0.93 ± 0.12

1.092

No

75(54.0)

0.90 ± 0.19

Sleep duration

Appropriate

111(79.9)

0.93 ± 0.11

2.733**

Inappropriate

28(20.1)

0.84 ± 0.28

Note. M mean, SD standard deviation, HCC Hepatocelluar carcinoma, Categories with superscripts(age, educational level and types of CLD), were group name for analyzing Scheffe's test. A>B : A was higher mean than B.

*P < 0.05, ** P < 0.01, ***P < 0.001

emissing value was excluded

Factors affecting HRQoL

To identify factors affecting HRQoL of patients with CLD, hierarchical regression analysis was performed (Table 2). In Model I, among socio-demographic characteristics (age, marital status, education level, occupation, BLSRS), marital status (P < 0.05), occupation (P < 0.01) and BLSRS (P < 0.05) were found to have significant associations, with an explanatory power of 25.6% (P < 0.001). When health status variables were entered (Model II), HCC (P < 0.05), SHS (P < 0.01) and depression (P < 0.001) were significant associated, with explanatory power of 39.8% (P < 0.001). When health behaviors (alcohol intake, sleep duration) variables were entered (Model III), results were insignificant.
Table 2

Factors influencing HRQoL (N = 129)

Predictor

Model I

Model II

Model III

Variables

ß

SE

ß

SE

ß

SE

(Constant)

.911

.045

.847

.051

.817

.067

1. Socio-demographic factors

 Age

− 244**

.001

−.192

.001

−.170

.001

 Marital status(ref: Living without partner)

.201*

.019

.160*

.017

.159*

.017

Education level(ref: ≤Elementary school)

 Middle school

.112

.022

.078

.020

.076

.020

 High school

.007

.021

.013

.019

.006

.019

 ≥College

−.129

.018

−.142

.016

−.144

.017

 Occupation(ref: No)

.231**

.015

.243**

.014

.221**

.014

 Basic livelihood security recipient(ref: Yes)

.187*

.025

.146

.023

.163*

.023

2. Health status factors

 Types of hepatic disease(ref:Hepatitis C)

  Hepatitis B

  

.014

.033

.012

.033

  Liver cirrohosis

  

−.135

.017

−.109

.017

  HCC

  

.188*

.022

.187*

.022

  Subjective health status(ref: Poor)

  

.218**

.018

.226**

.018

  Depression(ref: Yes)

  

.292***

.017

.273***

.017

  Medical co-morbidity(ref: Yes)

  

.045

.014

.040

.014

3. Health behavior factors

 Alcohol intake (ref: Yes)

    

.125

.014

 Sleep duration(ref: inappropriate)

    

.030

.017

 R2(R2 change)

.297

.459(.162)

.472(.013)

 Adjusted R2

.256

.398

.402

 F(p)

7.288(<.001)

7.506(<.001)

6.729(<.001)

Note. ref referent group, ß = regression coefficients, SE standard error, HCC Hepatocelluar carcinoma

* P < 0.05, ** P < 0.01, *** P < 0.001

Discussion

The mean of EQ-5D in Korean of CLD was 0.91, similar to the quality of life in the general population [23, 24], but higher than those with chronic obstructive pulmonary disease [13, 25] and CLD patients in Italy [26]. These differences might be due to variations in data collection. To better understand the quality of life of patients with CLD, an understanding of the characteristics and severity of disease is needed.

The HRQoL of CLD in Korea was found to be significantly different according to age, marital status, education level, occupation, BLSRS. Chinese CLD patients [27] have also shown significantly difference according to age and marital status. For US chronic hepatitis C patients [28], HRQoL is different according to gender, education level, and marital status. In Brazilian CLD patients [5], HRQoL is different according to economic status. However, in Germany [4], HRQoL of CLD patients has no association with age, gender, or economic status. These results of previous studies were inconsistent. This might be due to differences in the type of liver disease, research measurement tools, and so on. CLD is a disease prevalent in men in their 40s to 50s who are most active in economic activities. They might face problems such as disintegration of family and declining productivity of society. CLD not only affects individuals, but also the society. Therefore, it is necessary to understand factors influencing the HRQoL of Korean CLD patients through repeated researches. Spousal supports have positive effect on family livelihood and patient’s quality of life [27]. Therefore, supporting groups for CLD spouses are needed. Poor people are vulnerable groups who have economic difficulties arising from repeat hospitalization [2931] and the lack of self-management for health [32]. Therefore, a multidisciplinary nursing intervention program that considers various characteristics of CLD with low HRQoL is needed.

In this study, 85.6% of subjects recognized that they were unhealthy. Although depression was only reported by 17.4% of subjects, it was found to be a factor influencing the HRQoL. CLD patients with comorbidity showed low HRQoL in this study. However, previous studies have revealed inconsistent results with low [4] or high [28] quality of life depending on the type of liver disease. HRQoL is an important factor that should be evaluated for patients with chronic diseases. It can provide a balance between clinical and patient outcomes [33]. CLD subjects often have negative emotions such as psychological sensitivity and concern due to fatigue, ascites, and esophageal varices [3437]. Subject with hepatitis C were showed the lowest HRQoL. This result was also revealed in the precedent study [33, 38]. 60% of hepatitis C has converted to liver cirrhosis and HCC [39], side effects such as fatigue, depression, impotence etc. possessed by interferon which is a treatment have difficulties in home and work life [38]. Especially, the prevalence rate is as low as 0.6–0.8%, but 50–80% of the infected people are chronic condition, resulting in a great economic and psychological burden which is personal or national aspects. In Korea, it is managed as a third-party national infectious disease [40]. This burden of disease management seems to have lowered the HRQoL of the hepatitis C subjects. CLD needs various supportive care, including information and educational, practical, physical, psychological needs, and patient care support (support group, etc.) [41]. In this study, HRQoL of HCC was higher than previous studies [42, 43]. The QoL of HCC patients reported worse physical, emotional and functional QoL, but better social/family QoL compared with the general population [44]. This data was extracted from the KNHANES. This survey collected the data on subjects who can conduct a one-hour questionnaire and physical examination alone [45]. The HRQoL of HCC was closely related to liver function, tumor stage, recurrent HCC, fatigue, pain, nausea, and performance status [43]. Therefore, careful attention should be paid to the extended interpretation of this result, and repeated research is needed.

As health behavior variables, alcohol drinking and sleep duration showed significant differences in the HRQoL of CLD patients without affecting it. Alcohol drinking is a major predictor of liver disease [28]. Continuous drunk monitoring [46] and management program of adequate drinking are necessary to reduce the deterioration in HRQoL of CLD patients and prevent the increase of medical expenses. Similar to a previous study [47], CLD subjects with less than 6 h of sleep appeared to have poor quality of life. Adult and older adults were not recommended less than 6 h of sleep. Sleep, like diet and exercise, is a vital part of physical, cognitive, and emotional health [22]. Therefore, it will be necessary to have a repeated study to verify that affecting factors the quality of life such as alcohol and sleep of patients with CLD. Symptoms of fatigue and sleep disorder can reduce their quality of life. CLD occurred in those with abnormal circadian rhythm in a previous study [48]. Therefore, we need to assess factors affecting sleep disorder to provide sleep nursing intervention. Also, qualitative research is required to understand the health behavior affecting the HRQoL of CLD patients.

This study has several limitations. First, we had limitations that to assess depression, comorbidity and stress, validated methods are not used (ex. Beck depression inventory, Hamilton scale, Charlson Comorbidity Index, Perceived Stress Scale). The severity of CLD was not assessed by Child-Pugh or MELD (Model for End-Stage Liver Disease). We did not evaluated the patients had ascites or edema, because this was a secondary analysis of the KNHANES data. Second, there were restrictions in analyzing the causal relationship of various influence factors in the secondary analysis of the KNHANES data. Caution is needed when expanding and interpreting our research results due to the lack of prior research measured with EQ-5D. Despite these limitations, the result from this study came from a sample based on nationally representative data. We evaluated HRQoL of CLD through EQ-5D. The results of this study can be compared other national or disease of HRQoL and used as basis data to develop community based health programs for patients with CLD.

Conclusion

In this study, we analyzed the sixth KNHANES in order to grasp factors influencing the HRQoL of patients with CLD in Korea. As a result, marital status, occupation, BLSRS, SHS, depression and HCC were confirmed as affecting factors, health behavior variables were not significant. Alcohol intake has a negative effect on liver function. But, the HRQoL of those who intake an alcohol is significantly higher. We should be provide to continuous monitoring and education of adequate alcohol intake for patients with CLD. Future research will require a longitudinal study and a cohort approach to obtain a deeper understanding of health behavior and causal relationship with HRQoL in Korean CLD. And HRQoL studies of CLD patients should be undertaken through application of validated measurement tool.

Abbreviations

BLSRS: 

Basic livelihood security recipient status

CLD: 

Chronic liver disease

EQ-5D: 

EuroQol five-dimension

HCC: 

Hepatocelluar carcinoma

HRQoL: 

Health-related quality of life

KCDC: 

Korea Centers for Disease prevention and Control

KNHANES: 

Korea National Health and Nutrition Examination Survey

SHS: 

Subjective health status

Declarations

Availability of data and materials

The datasets of this article are available in the Korea Centers for Disease Control and Prevention website (https://knhanes.cdc.go.kr/knhanes/sub03/sub03_02_02.do).

Authors’ contributions

HJK, RN, MSN. designed the research plan. HSC, RN, MSN. made substantial contributions to acquisition and analysis of data available on the Korea Centers for Disease Control and Prevention Website. SL, RN, PhD. is interpreted data and drafted the manuscript. All the authors reviewed and approved the final version of the manuscript.

Ethics approval and consent to participate

KNHANES was an annual survey conducted by the Research Ethics Review Committee of the KCDC (No. 2013-07CON-03-4C, No. 2013-12EXP-03-5C, No. 2015–01-02-6C). All personal identification information was deleted from the data before analysis. Participants in this survey provided their informed consent.

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Quality Improvement, Hanyang University Hospital, 222-1, Wangsimni-ro Seongdong-gu, Seoul, 04763, Republic of Korea
(2)
Hanyang Cell Therapy Center, Hanyang University Hospital, 222-1, Wangsimni-ro Seongdong-gu, Seoul, 04763, Republic of Korea
(3)
Department of Nursing, Gyeongnam National University of Science and Technology, 33, Dongjin-ro, Jinju-si, Gyeongsangnam-do, 52725, Republic of Korea

References

  1. Statistics Korea. Cause of death statistics [Intenet]. Sejong: Korean Statistical Information Service 2016[cited 2017 September 22]. Aavailable from: http://www.kostat.go.kr.
  2. Afendy A, Kallman JB, Stepanova M, Younoszai Z, Aquino RD, Bianchi G, et al. Predictors of health-related quality of life in patients with chronic liver disease. Aliment Pharmacol Ther. 2009;30(5):469–76. https://doi.org/10.1111/j.1365-2036.2009.04061.x.View ArticlePubMedGoogle Scholar
  3. Korea Centers for Disease Control and Prevention [KCDC]. Korea health statistics 2012: Korea national health and nutrition examination survey (KNHANES IV): Current status and challenges. Osong, South Korea: KCDC; 2012.Google Scholar
  4. Häuser W, Holtmann G, Grandt D. Determinants of health-related quality of life in patients with chronic liver diseases. Clin Gastroenterol Hepatol. 2004;2(2):157–63. https://doi.org/10.1016/S1542-3565(03)00315-X.View ArticlePubMedGoogle Scholar
  5. Souza NP, Villar LM, Garbin AJ, Rovida TA, Garbin CA. Assessment of health-related quality of life and related factors in patients with chronic liver disease. Braz J Infect Dis. 2015;19(6):590–5. https://doi.org/10.1016/j.bjid.2015.08.003.View ArticlePubMedGoogle Scholar
  6. Younossi ZM, Boparai N, Price LL, Kiwi ML, Mc Cormick M, Guyatt G. Health-related quality of life in chronic liver disease: the impact of type and severity of diseases. Am J Gastroenterol. 2001;96(7):2199–205. https://doi.org/10.1111/j.1572-0241.2001.03956.x. View ArticlePubMedGoogle Scholar
  7. Ware JE, Bayliss MS, Mannocchia M, Davis GL. Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. Hepatolog. 1999;30:550–5.View ArticleGoogle Scholar
  8. Park SH, Yang JH. Factors associated with quality of life in patients with chronic liver disease. J Korean Data Anal Soc. 2013;15:223–36.Google Scholar
  9. Rocca P, Cocuzza E, Rasetti R, Rocca G, Zanalda E, Bogetto F. Predictors of psychiatric disorders in liver transplantation candidates: logistic regression models. Liver Transpl. 2003;9(7):721–6. https://doi.org/10.1053/jlts.2003.50133.View ArticlePubMedGoogle Scholar
  10. Park CK, Park SY, Kim ES, Park JH, Hyun DW, Yun YM, et al. Assessment of quality of life and associated factors in patients with chronic viral liver disease. Clin Mol Hepatol. 2003;9:212–21.Google Scholar
  11. Sobhonslidsuk A, Silpakit C, Kongsakon R, Satitpornkul P, Sripetch C, Khanthavit A. Factors influencing health-related quality of life in chronic liver disease. World J Gastroenterol. 2006;12(48):7786–91. https://doi.org/10.1053/jlts.2003.50133. View ArticlePubMedPubMed CentralGoogle Scholar
  12. Kim KS, Yi M, Choi EO, Paik SW, Kwak S, Kwon SH. Quality of life and related factors in patients with chronic hepatitis B. J Korean Acad Fundam Nurs. 2007;14:331–9.Google Scholar
  13. Jung YM, Lee HY. Chronic obstructive pulmonary disease in Korea: prevalence, risk factors, and quality of life. J Korean Acad Nurs. 2011;41(2):149–56. https://doi.org/10.4040/jkan.2011.41.2.149.View ArticlePubMedGoogle Scholar
  14. Lee JJ, Lee HJ, Park EJ. Effect of staged education program for hypertension, diabetes patients in a community (assessment of quality of life using EQ-5D). J Agric Med Community Health. 2014;39(1):37–45. https://doi.org/10.5393/JAMCH.2014.39.1.037.View ArticleGoogle Scholar
  15. Lee KE, Cho EH. Factors influencing health related quality of life in patients with hypertension: based on the 5th Korean National Health and nutrition examination survey. J Korea Contents Assoc. 2016;16(5):399–409. https://doi.org/10.5392/JKCA.2016.16.05.399.View ArticleGoogle Scholar
  16. Korea Centers for Disease Control and Prevention [KCDC]. Korea health statistics 2015: Korea national health and nutrition examination survey (KNHANES VI-2). KCDC: Osong, South Korea; 2016.Google Scholar
  17. EuroQol group. EuroQol–a new facility for the measurement of health-related quality of life. the EuroQol Group Health Policy. 1990;16:199–208.View ArticleGoogle Scholar
  18. Korea Centers for Disease Control and Prevention [KCDC].Korea health statistics 2010: South Korean time trade-off values for EQ-5D health states. KCDC: Osong, South Korea; 2010.Google Scholar
  19. Han MA, Kim KS, Park J, Kang MG, Ryu SY. Association between levels of physical activity and poor self-rated health in Korean adults: the third Korea National Health and nutrition examination survey (KNHANES), 2005. Public Health. 2009;123(10):665–9. https://doi.org/10.1016/j.puhe.2009.08.005.View ArticlePubMedGoogle Scholar
  20. Korean Society for the Study of Obesity. Obesity diagnostic criteria. Seoul; 2000 Guide to obesity treatment. Seoul: Han-wui hak;2000.Google Scholar
  21. Korea Ministry of Health and Welfare. 2016 Community Integrated Health Promotion Project Guide –Physical Activity. Korea Ministry of Health and Welfare; 2016.Google Scholar
  22. Hirshkowitz M, Whiton K, Albert SM, Alessi C, Bruni O, DonCarlos L, et al. National Sleep Foundation's sleep time duration recommendations: methodology and results summary. Sleep Health. 2015;1(1):40–3. https://doi.org/10.1016/j.sleh.2014.12.010.View ArticlePubMedGoogle Scholar
  23. Jia H, Lubetkin EI. The statewide burden of obesity, smoking, low income and chronic diseases in the United States. J Public Health. 2009;31(4):496–505. https://doi.org/10.1093/pubmed/fdp012.View ArticleGoogle Scholar
  24. Seong SS, Choi CB, Sung YK, Park YW, Lee HS, Uhm WS, et al. Health-related quality of life using EQ-5D in Koreans. J Korean Rheum Assoc. 2004;11(3):254–62.Google Scholar
  25. Pickard AS, Wilke C, Jung E, Patel S, Stavem K, Lee TA. Use of a preference-based measure of health (EQ-5D) in COPD and asthma. Respir Med. 2008;102(4):519–36. https://doi.org/10.1016/j.rmed.2007.11.016.View ArticlePubMedGoogle Scholar
  26. Scalone L, Ciampichini R, Fagiuoli S, Gardini I, Fusco F, Gaeta L, et al. Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases. Qual Life Res. 2013;22(7):1707–16. https://doi.org/10.1007/s11136-012-0318-0.View ArticlePubMedGoogle Scholar
  27. Gao R, Gao F, Li G, Hao JY. Health-related quality of life in Chinese patients with chronic liver disease. Gastroenterol Res Pract. 2012;2012:516140. https://doi.org/10.1155/2012/516140. View ArticlePubMedPubMed CentralGoogle Scholar
  28. Hussain KB, Fontana RJ, Moyer CA, Su GL, Sneed-Pee N, Lok ASF. Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C. Am J Gastroenterol. 2001;96(9):2737–44. https://doi.org/10.1111/j.1572-0241.2001.04133.x.View ArticlePubMedGoogle Scholar
  29. Basal A, Kamel E, Nafady H. Studying the quality of life of chronic hepatitis C patients and the associated factors. J Am Sci. 2011;7:649–55.Google Scholar
  30. Chang SC, Yang SS, Chang CC, Lin CC, Chung YC, Li TC. Assessment of health-related quality of life in antiviral-treated Taiwanese chronic hepatitis C patients using SF-36 and CLDQ. Health Qual Life Outcomes. 2014;12(1):97. https://doi.org/10.1186/1477-7525-12-97.View ArticlePubMedPubMed CentralGoogle Scholar
  31. Kim JO, Kim MW, Kim JS, Han SJ, Kim S. Factors influencing health related quality of life among patients with chronic hepatitis B. Korean J Adult Nurs. 2014;26(3):287–99. https://doi.org/10.7475/kjan.2014.26.3.287.View ArticleGoogle Scholar
  32. Park DS, Ma SJ. Choi KE. Current situation of the rural vulnerable class and policy improvement measures: centered on the elderly living alone and grandparents-grandchildren families. Seoul: Korea Rural Economic Institute Basic Research Report; 2010.Google Scholar
  33. Orr JG, Homer T, Ternent L, Newton J, McNeil CJ, Hudson M, et al. Health related quality of life in people with advanced chronic liver disease. J Hepatol. 2014;61(5):1158–65. https://doi.org/10.1016/j.jhep.2014.06.034.View ArticlePubMedGoogle Scholar
  34. Van der Plas SM, Hansen BE, de Boer JB, Stijnen T, Passchier J, de Man RA, et al. Generic and disease-specific health related quality of life in non-cirrhotic, cirrhotic and transplanted liver patients: a cross-sectional study. BMC Gastroenterol. 2003;3:33. https://doi.org/10.1186/1471-230X-3-33.View ArticlePubMedPubMed CentralGoogle Scholar
  35. Gutteling JJ, De Man RA, Van der Plas SM, Schalm SW, Busschbach JJ, Darlington ASE. Determinants of quality of life in chronic liver patients. Aliment Pharmacol Ther. 2006;23(11):1629–35. https://doi.org/10.1111/j.1365-2036.2006.02934.x.View ArticlePubMedGoogle Scholar
  36. Gao F, Gao R, Li G, Shang ZM, Hao JY. Health-related quality of life and survival in Chinese patients with chronic liver disease. Health Qual Life Outcomes. 2013;11:131. https://doi.org/10.1186/1477-7525-11-131.View ArticlePubMedPubMed CentralGoogle Scholar
  37. Steel JL, Chopra K, Olek MC, Carr BI. Health-related quality of life: hepatocellular carcinoma, chronicliver disease, and the general population. Qual Life Res. 2007;16(2):203–15. https://doi.org/10.1007/s11136-006-9111-2.View ArticlePubMedGoogle Scholar
  38. Gutteling JJ, de Man RA, Busschbach JJ, Darlington AS. Overview of research on health-related quality of life in patients with chronic liver disease. Neth J Med. 2007;65(7):227–34.PubMedGoogle Scholar
  39. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect. 2011;17(2):107–15. https://doi.org/10.1111/j.1469-0691.2010.03432.x.View ArticlePubMedGoogle Scholar
  40. Jeong SH, Jang ES, Choi HW, Kim KA, Chung W, Ki M. Current Status of Hepatitis C Virus Infection and Countermeasures in South Korea. 2017; 39: 1–7. https://doi.org/10.4178/epih.e2017017
  41. Valery PC, Powell E, Moses N, Volk ML, McPhail SM, Clark PJ, et al. Systematic review: unmet supportive care needs in people diagnosed with chronic liver disease. BMJ Open. 2015;5(4):e007451. https://doi.org/10.1136/bmjopen-2014-007451.View ArticlePubMedPubMed CentralGoogle Scholar
  42. Gandhi S, Khubchandani S, Iyer R. Quality of life and hepatocellular carcinoma. J Gastrointest Oncol. 2014;5(4):296–317. https://doi.org/10.3978/j.issn.2078-6891.2014.046. PubMedPubMed CentralGoogle Scholar
  43. Sternby Eilard M, Hagström H, Mortensen KE, Wilsgaard T, Vagnildhaug OM, Dajani O, Stål P, Rizell M. Quality of life as a prognostic factor for survival in hepatocellular carcinoma. Liver Int. 2018;38(5):885–94. https://doi.org/10.1111/liv.13593.View ArticlePubMedGoogle Scholar
  44. Fan SY, Eiser C, Ho MC. Health-related quality of life in patient with hepatocellular carcinoma: a systematic review. Clin Gastroenterol Hepatol. 2010;8:559–64.View ArticlePubMedGoogle Scholar
  45. Korea Centers for Disease Control and Prevention [KCDC]. Guidelines for utilization of the 6th the Korea National Health and Nutrition Examination Survey (KNHANES) data. South Korea: KCDC; 2017.Google Scholar
  46. Do ES, Lee SM, Seo YS. Related factors of quality of life in middle-male with chronic liver disease. J Digit Convergence. 2015;3(2):267–77. https://doi.org/10.14400/JDC.2015.13.2.267.View ArticleGoogle Scholar
  47. Kim S, Choi KH, Hwang SG, Lee JH, Kwak SY, Park PW, et al. Validation of the Korean version of liver disease quality of life (LDQOL 1.0) instrument. Korean J Hepatol. 2007;13:44–50.PubMedGoogle Scholar
  48. De Cruz S, Espiritu JRD, Zeidler M, Wang TS. Sleep disorders in chronic liver disease. Semin Respir Crit Care Med. 2012;33(1):26–35. https://doi.org/10.1055/s-0032-1301732.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2018

Advertisement